Post-Transplantation Lymphoproliferative disorders localizing in the adenotonsillar region: Report from the PTLD.Int survey

Annals of Transplantation

Volumn 16, Issue 1, 2011, Pages 109-116

  Khedmat, Hossein ^a   Taheri, Saeed ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Taheri Medical Research Group   (Iran)

Author keywords

Adenotonsillar hypertrophy; Localization of neoplasm; Post transplant lymphoproliferative disorders; PTLD

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TONSIL DISEASE;

ADENOIDS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; ORGAN TRANSPLANTATION; PALATINE TONSIL; POSTOPERATIVE COMPLICATIONS; YOUNG ADULT;

EID: 79953285890     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pourfarziani V, Taheri S, Sharifi-Bonab MM, Mohammadzadeh M: Assessment of sleep disturbance in renal transplant recipients and associated risk factors. Saudi J Kidney Dis Transpl, 2010; 21(3): 433-37
2. Khedmat H, Alavian SM, Taheri S: Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. Ann Transplant, 2010; 15(2): 40-44
3. Khedmat H, Taheri S: Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(4): 80-85
4. Boubenider S, Hiesse C, Goupy C et al: Incidence and consequences of post transplantation lymphoproliferative disorders. J Nephrol, 1997; 10: 135-45
5. Harris NL, Swerdlow SH, Frizzera G et al: Posttransplant lymphoproliferative disorders. In: Jaffe E, Harris N, Stein H et al., (eds.), Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. Lyon, France: IARC Press, 2001; 264-69
6. Broughton S, McClay JE, Murray A et al: The effectiveness of tonsillectomy in diagnosing lymphoproliferative disease in pediatric patients after liver transplantation. Arch Otolaryngol Head Neck Surg, 2000; 126: 1444-47
7. Herrmann BW, Sweet SC, Molter DW: Sinonasal posttransplant lymphoproliferative disorder in pediatric lung transplant patients. Otolaryngol Head Neck Surg, 2005; 133: 38
8. Ganne V, Siddiqi N, Kamaplath B et al: Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for posttransplant lymphoproliferative disorder. Clin Transplant, 2003; 17: 417
9. Collins MH, Montone KT, Leahey AM et al: Posttransplant lymphoproliferative disease in children. Pediatr Transplant, 2001; 5: 250-57
10. Kerkar N, Morotti RA, Madan RP et al: The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant, 2010; 14(4): 504-11
11. Djokic M, Le MM, Swinnen LJ et al: Post- Transplant Lymphoproliferative Disorder Subtypes Correlate with Different Recurring Chromosomal Abnormalities. Genes Chromosomes Cancer, 2006; 45(3): 313-18
12. Allen UD, Farkas G, Hebert D et al: Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case - control study. Pediatr Transplant, 2005; 9: 450-55
13. Gerstenkorn C, Jackson G, Di Franco F et al: Outcome of PTLD in renal and liver allograft recipients. Transplant Proc, 2001; 33(4): 2469-72
14. Schubert S, Renner C, Hammer M et al: Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. J Heart Lung Transplant, 2008; 27: 100-5
15. Ho M, Miller G, Atchison RW: Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis, 1985; 152: 876
16. Vakiani E, Basso K, Klein U et al: Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol, 2008; 26: 199-211
17. Wilde GE, Moore DJ, Bellah RD: Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease. AJR Am J Roentgenol, 2005; 185(5): 1335-41
18. Lucioni M, Ippoliti G, Campana C et al: EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant, 2004; 4(11): 1915-20
19. Poirel HA, Bernheim A, Schneider A: Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status. Transplantation, 2005; 80(2): 176-84
20. Berney T, Delis S, Kato T et al: Successful treatmentof posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation, 2002; 74: 1000
21. Smets F, Vajro P, Cornu G et al: indications and results of chemotherapy in children with post-transplant lymphoproliferative disease after liver transplantation. Transplantation, 2000; 69: 982-85
22. Kenagy DN, Schlesinger Y,Weck K et al: Epstein- Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation, 1995; 60: 547-54
23. Hanto DW, Gajl-Peczalska KJ, Frizzera G et al: Epstein- Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg, 1983; 198: 356-69
24. Craig FE, Gulley ML, Banks PM: Posttransplantation lymphoproliferative disorders. Am J Clin Pathol, 1993; 99: 265
25. Peraira JR, Segovia J, Fuertes B et al: Current induction immunosuppression and post-heart transplant lymphoproliferative disorders. Transplant Proc, 2003; 35(5): 2009-10
26. Manlhiot C, Pollock-Barziv SM, Holmes C et al: Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. J Heart Lung Transplant, 2010; 29(6): 648-57
27. Ziarkiewicz-Wroblewska B, Gornicka B, Suleiman W et al: Posttransplant lymphoproliferative disorder: Morphological picture and diagnostic difficulties. Transplant Proc, 2006; 38: 168
28. Mucha K, Foroncewicz B, Niemczyk K et al: Tonsil enlargement after liver transplantation in adults - reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease. Liver Transpl, 2007; 13(6): 918-923
29. Pourfarziani V, Taheri S, Lessan-Pezeshki M et al: Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol, 2008; 40(4): 1089-94
30. Khedmat H, Taheri S: Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(3): 74-77
31. Nalesnik M, Jaffe R, Starzl TE et al: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol, 1988; 133: 173-92
32. Khedmat H, Taheri S: Characteristics and Prognosis of Post Transplantation Lymphoproliferative Disorders within Renal Allograft: Report from PTLDint Survey. Ann Transplant, 2010; 15(3): 80-86
33. Khedmat H, Taheri S: Post Transplantation Lymphoproliferative Disorders in Renal vs. Simultaneous Renal- Pancreas Allograft recipients: Report from PTLD.Int. Survey. Saudi J Kidney Dis Transpl, (Accepted)
34. Izadi M, Taheri S: Significance of in Situ Hybridization Results for EBV-Encoded RNA in Post Transplantation Lymphoproliferative Disorder Setting: Report from the PTLD.Int. Survey. Ann Transplant, 2010; 15(4): 102-9
35. Williamson RA, Huang RY, Shapiro NL: Adenotonsillar histopathology after organ transplantation. Otolaryngol Head Neck Surg, 2001; 125: 231-40
36. Meru N, Davison S, Whitehead L et al: Epstein- Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens. Mol Pathol, 2001; 54(4): 264-69
37. Shapiro NL, Strocker AM: Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients. The Laryngoscope, 2001; 111: 997-1001
38. Shapiro NL, Strocker AM, Bhattacharyya N: Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation. Int J Pediatr Otorhinolaryngol, 2003; 67(2): 151-55
39. Ho M: Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc, 1995; 27: 38-40
40. De Diego JI, Prim MP, Hardisson D et al: Posttransplant lymphoproliferative disease in tonsils of children with liver transplantation. Int J Pediatr Otorhinolaryngol, 2001; 58(2): 113-18